322 related articles for article (PubMed ID: 31979293)
1. Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs.
Vitale C; Montalbano MC; Salvetti C; Boccellato E; Griggio V; Boccadoro M; Coscia M
Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31979293
[TBL] [Abstract][Full Text] [Related]
2. The Role of Novel Agents in Treating CLL-Associated Autoimmune Hemolytic Anemia.
Noto A; Cassin R; Mattiello V; Reda G
J Clin Med; 2021 May; 10(10):. PubMed ID: 34065833
[TBL] [Abstract][Full Text] [Related]
3. A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.
Tsang M; Parikh SA
Curr Hematol Malig Rep; 2017 Feb; 12(1):29-38. PubMed ID: 28197963
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendations.
De Back TR; Kater AP; Tonino SH
Expert Rev Hematol; 2018 Aug; 11(8):613-624. PubMed ID: 29923432
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune Cytopenia in CLL: Prognosis and Management in the Era of Targeted Therapies.
Albiol N; Moreno C
Cancer J; 2021 Jul-Aug 01; 27(4):286-296. PubMed ID: 34398555
[TBL] [Abstract][Full Text] [Related]
6. Pure red cell aplasia occurring during ibrutinib therapy for chronic lymphocytic leukemia.
Wang L; Wu S; Yu G; Sui X; Chu X; Liu X
J Oncol Pharm Pract; 2023 Dec; 29(8):2031-2036. PubMed ID: 37518980
[TBL] [Abstract][Full Text] [Related]
7. Clinical and serological autoimmune complications in chronic lymphocytic leukemia.
Demir C; Ekinci Ö
Wien Klin Wochenschr; 2017 Aug; 129(15-16):552-557. PubMed ID: 28477093
[TBL] [Abstract][Full Text] [Related]
8. Chronic lymphocytic leukemia therapy: new targeted therapies on the way.
Vitale C; Burger JA
Expert Opin Pharmacother; 2016 Jun; 17(8):1077-89. PubMed ID: 26988407
[TBL] [Abstract][Full Text] [Related]
9. [Improvement of autoimmune cytopenia with ibrutinib in a chronic lymphocytic leukemia patient complicated by monoclonal immunoglobulin deposition disease].
Nakamura M; Yoshioka S; Yamashita D; Hara S; Ishikawa T
Rinsho Ketsueki; 2019; 60(10):1449-1454. PubMed ID: 31695006
[TBL] [Abstract][Full Text] [Related]
10. Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections.
Hilal T; Gea-Banacloche JC; Leis JF
Blood Rev; 2018 Sep; 32(5):387-399. PubMed ID: 29571669
[TBL] [Abstract][Full Text] [Related]
11. The prevalence and prognostic significance of autoimmune cytopenias in a cohort of Egyptian patients with chronic lymphocytic leukemia.
Atef B; Azmy E; Aladle D; Mabed M
Hematol Oncol Stem Cell Ther; 2019 Jun; 12(2):97-104. PubMed ID: 30802421
[TBL] [Abstract][Full Text] [Related]
12. Basic biology of autoimmune phenomena in chronic lymphocytic leukemia.
Pritsch O; Maloum K; Dighiero G
Semin Oncol; 1998 Feb; 25(1):34-41. PubMed ID: 9482525
[TBL] [Abstract][Full Text] [Related]
13. Relapsed/Refractory Chronic Lymphocytic Leukemia: Chemoimmunotherapy, Treatment until Progression with Mechanism-Driven Agents or Finite-Duration Therapy?
Cuneo A; Foà R
Mediterr J Hematol Infect Dis; 2019; 11(1):e2019024. PubMed ID: 30858962
[TBL] [Abstract][Full Text] [Related]
14. Current Treatment of Chronic Lymphocytic Leukemia.
Jamroziak K; Puła B; Walewski J
Curr Treat Options Oncol; 2017 Jan; 18(1):5. PubMed ID: 28185174
[TBL] [Abstract][Full Text] [Related]
15. Infections in patients with chronic lymphocytic leukaemia: Mitigating risk in the era of targeted therapies.
Teh BW; Tam CS; Handunnetti S; Worth LJ; Slavin MA
Blood Rev; 2018 Nov; 32(6):499-507. PubMed ID: 29709246
[TBL] [Abstract][Full Text] [Related]
16. Magic pills: new oral drugs to treat chronic lymphocytic leukemia.
Vitale C; Griggio V; Todaro M; Salvetti C; Boccadoro M; Coscia M
Expert Opin Pharmacother; 2017 Mar; 18(4):411-425. PubMed ID: 28234562
[TBL] [Abstract][Full Text] [Related]
17. [Chronic lymphocytic leukemia: pathophysiology and current therapy].
Takizawa J
Rinsho Ketsueki; 2017; 58(5):471-479. PubMed ID: 28592762
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia.
Diehl LF; Ketchum LH
Semin Oncol; 1998 Feb; 25(1):80-97. PubMed ID: 9482530
[TBL] [Abstract][Full Text] [Related]
19. Balancing efficacy and toxicity of targeted agents currently used for the treatment of patients with chronic lymphocytic leukemia.
Mauro FR; Caputo MD; Rosati S; Pepe S; De Benedittis D; De Luca ML; Foà R
Expert Rev Hematol; 2018 Aug; 11(8):601-611. PubMed ID: 29969322
[TBL] [Abstract][Full Text] [Related]
20. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia.
Barcellini W; Capalbo S; Agostinelli RM; Mauro FR; Ambrosetti A; Calori R; Cortelezzi A; Laurenti L; Pogliani EM; Pedotti P; Liso V; Girelli G; Mandelli F; Zanella A;
Haematologica; 2006 Dec; 91(12):1689-92. PubMed ID: 17145607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
